After the approval of safe and highly effective oral direct acting agents (DAA) for the treatment of hepatitis C virus (HCV) in 2014, commentaries and discussions about the elimination of hepatitis C on a population level have rapidly proliferated in scientific literature and popular press. Indeed, the World Health Organization (WHO) has announced proposed global targets of an 80% reduction in new cases of HCV infection from the 2010 level and several countries, including Australia, Egypt, Georgia and Iceland have embarked on ambitious plans to control HCV infection in their populations.

To read the full article, published in Journal of Hepatology, click here.

Original Article

Related News

1371

Behavioral intervention reduces HIV transmission risk in young transgender women

1720

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

1702

Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe

1615

Patient Communities Agree on Shared Vision of HIV Treatment Regimen

2071

Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection